Key Highlights from an ACCC Survey on Remote Patient Monitoring

Remote patient monitoring is a type of telehealth that allows patients to share data about their health with their care team in between clinic visits, including symptoms and vitals. Symptom tracking and monitoring technologies allow better management of treatment side effects, in turn allowing longer administration of treatments and improved clinical outcomes. While advantages to remote patient monitoring are well-known and documented in the literature, translation into clinical practice must account for patient preferences, equity considerations, financial sustainability, and patient/provider education needs.  In 2022, ACCC conducted a survey to measure patient, caregiver, and provider perceptions and adoption of messaging tools, electronic questionnaires, and connected devices used to track and monitor symptoms during cancer treatment. This podcast shares key survey findings. Guest: David Penberthy, MD, MBA Associate Professor of Radiation Oncology Penn State Health, Milton S. Hershey Medical Center Immediate Past President Association of Community Cancer Centers "Through the pandemic, healthcare has been contending with workforce shortages, and so everybody is concerned about how we do more with less. Using digital tools can actually help facilitate patient engagement with the healthcare team—hopefully keeping people out of the hospital and intervening earlier so we can achieve more of what we're trying to achieve of maintaining health as opposed to just reacting to illness."  Read more here. Resources: Remote Patient Monitoring: The New Frontier in Telemedicine Opportunities Changing the Tune for CAR T-Cell Therapy: A Music City Experience in Remote Patient Monitoring Remote Patient Monitoring and Health Equity Telehealth Success Stories: Remote Symptom Monitoring Using Patient Reported Outcomes Chemotherapy Care Companion: An Oncology Remote Patient Monitoring Program Remote Home Monitoring of Patients with Cancer During the COVID-19 Pandemic This project is supported by AstraZeneca.